Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
What Are Merck’s Key Diabetes Products?
Market Realist
Mon, 08/15/16 - 11:05 am
Merck
diabetes
Januvia
Janumet
Emperra Launches First Bluetooth-Enabled Insulin Pen For Diabetes Management
Xtalks
Fri, 08/12/16 - 09:50 am
Emperra
devices
insulin
insulin pen
diabetes
MannKind maps out Afrezza strategy
BioPharma Dive
Wed, 08/10/16 - 06:25 pm
MannKind
Afrezza
diabetes
inhaled insulin
MannKind - Afrezza Scripts Lose Some Traction; Investors Need To Think About Realistic Impacts
Seeking Alpha
Tue, 08/9/16 - 11:29 am
MannKind
Afrezza
diabetes
inhaled insulin
Novo's insulin pill shows promise in mid-stage trial
Yahoo/Reuters
Fri, 08/5/16 - 11:32 am
Novo Nordisk
clinical trials
diabetes
insulin
OI338GT
Novo’s Victoza Diabetes Medicine Rebuffed by Express Scripts
Bloomberg
Tue, 08/2/16 - 08:50 am
Novo Nordisk
Express Scripts
Victoza
PBMs
diabetes
Mannkind Assumes Responsibility for Distribution of Afrezza® and Launches Patient Reimbursement and Adherence Support Programs
Yahoo
Tue, 08/2/16 - 08:45 am
MannKind
Afrezza
diabetes
inhaled insulin
Merck Results Underscore Need To Go Big Or Go Home In Diabetes Market
Forbes
Fri, 07/29/16 - 08:47 pm
Merck
diabetes
Sanofi
Januvia
Lantus
Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes
Yahoo
Wed, 07/27/16 - 09:56 pm
Sanofi
FDA
Adlyxin
diabetes
FDA readies panel on diabetes dosing label for Dexcom’s G5 CGM
Mass Device
Thu, 07/21/16 - 09:00 am
FDA
advisory panels
devices
diabetes
DexCom
blood glucose monitoring
G5 CGM
AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe
Fierce Pharma
Wed, 07/20/16 - 11:02 am
AstraZeneca
diabetes
Europe
FDA
Qtern
Farixga
Onglyza
No Clear Survival Benefit Seen Among Diabetes Drugs, But Meta-analysis Hampered by Limitations of Included Studies
MedPage Today
Wed, 07/20/16 - 09:23 am
diabetes
U.S. FDA expands indication for type 2 diabetes treatment Synjardy to include treatment-naïve adults
Yahoo
Wed, 07/20/16 - 02:25 pm
diabetes
Synjardy
type 2 diabetes
MannKind - Afrezza Scripts Starting Off Modestly On Relaunch
Seeking Alpha
Sat, 07/16/16 - 12:45 pm
MannKind
Afrezza
inhaled insulin
diabetes
JDRF backs Defymed for artificial pancreas study
Mass Device
Wed, 07/13/16 - 04:01 pm
diabetes
JDRF
artificial pancreas
Defymed
Mailpan
type 1 diabetes
devices
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
diabetes
Novo Nordisk
Eli Lilly
GLP-1 agonist
Victoza
Trulicity
MannKind 2.0 Launch: No Room For Error
Seeking Alpha
Fri, 07/1/16 - 09:36 am
MannKind
Afrezza
drug launches
inhaled insulin
diabetes
U.S. panel backs claim Lilly diabetes drug cuts cardiac death
Yahoo/Reuters
Tue, 06/28/16 - 10:55 pm
FDA
advisory panels
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Seeking Alpha
Tue, 06/28/16 - 05:33 pm
Eli Lilly
Lantus
biosimilars
diabetes
Basaglar
Inhaled insulin company Mannkind hiring med tech sales reps to recover from failed marketing partnership with Sanofi
Mass Device
Tue, 06/28/16 - 11:22 am
MannKind
hirings
Afrezza
diabetes
inhaled insulin
Sanofi
devices
device reps
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »